Inhibition of doxorubicin-initiated membrane damage by N-acetylcysteine: Possible mediation by a thiol-dependent, cytosolic inhibitor of lipid peroxidation
- 1 November 1988
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 96 (2) , 175-184
- https://doi.org/10.1016/0041-008x(88)90078-6
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- GSH‐dependent inhibition of lipid peroxidation: Properties of a potent cytosolic system which protects cell membranesLipids, 1985
- Lipid peroxidation and possible hydroxyl radical formation stimulated by the self-reduction of a doxorubicin-iron (III) complexBiochemical Pharmacology, 1984
- Indication of reduced doxorubicin-induced cardiac toxicity by additional treatment with antioxidative substancesCellular and Molecular Life Sciences, 1983
- Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine.Journal of Clinical Investigation, 1981
- Glutathione-dependent inhibition of lipid peroxidation by a soluble, heat-labile factor in animal tissuesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- Rat hepatic cytosolic glutathione-dependent enzyme protection against lipid peroxidation in the nadph-microsomal lipid peroxidation systemBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- Enzymatic Defenses of the Mouse Heart Against Reactive Oxygen MetabolitesJournal of Clinical Investigation, 1980
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977
- Cardiotoxicity of adriamycin and related anthracyclinesCancer Treatment Reviews, 1976
- A clinicopathologic analysis of adriamycin cardiotoxicityCancer, 1973